Metabolomics at the cutting edge of risk prediction of MASLD
En Ying Tan, Mark D. Muthiah, Arun J. Sanyal · 2024
Read Metabolomics at the cutting edge of risk prediction of MASLD by En Ying Tan, Mark D. Muthiah, Arun J. Sanyal (2024) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-11722125.txt.
Description
En Ying Tan and co-authors survey metabolite marks for fatty liver risk in a 2024 review. Metabolic dysfunction steatohepatitis liver disease is a world scale health threat, and firm blood marks for staging it are lacking. Blood metabolites mirror both body wide strain and liver change.
The review sorts shifts by disease trait: fat plus inflammation, activity grade, and scar stage. Panels built from metabolite sets earn a hard look for real world fit. The authors weigh each panel biology and clinic worth, then flag what proof must come next before wide use. Fit for purpose testing is the ask.
Catalog record
| CREATOR | En Ying Tan, Mark D. Muthiah, Arun J. Sanyal |
|---|---|
| YEAR | 2024 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 75 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |